- Current price
- Min Amount
- Earliest start
- 31 Dec 21:00
Invest in Cohesity
Cohesity Data Platform empowers companies to manage and store major data arrays, thus facilitating the data processing, increasing their security level and allowing companies to quickly find necessary files.
The company's customers include four of the Fortune top 10 as well as three of the top ten US banks and three of the top five US health insurers.
Cohesity was named a Leader in the 2021 Gartner Magic Quadrant for Enterprise Backup and Recovery Software Solutions report for the second consecutive year and was recognized as one of prestigious 2021 Forbes Cloud 100 companies for three straight years.
The global enterprise data management market size is expected to reach $208.87 billion by 2028, registering a CAGR of 13.8%. The outbreak of COVID-19 pandemic has triggered an estimated increase in the data management software demand due to the massive shift to working from home.
Cohesity saw a 40% increase YoY (July 31, 2021 over July 31, 2020) in the number of customers doing business with the company, with rapid adoption in the Americas, EMEA, and Asia Pacific regions. Cohesity customer count is now approximately 2,600. Nearly 25% of the Fortune 500 does business with Cohesity, an increase of more than 35% compared to the previous year.
Cohesity faces strong competition in the data management industry from a number of firms, including its closest rival Rubrik. This may negatively affect its long-term viability and valuation.
In 2021 Cohesity’s annual revenue run rate surpassed $300 million. The company also achieved more than a 70% increase YoY in annual recurring revenue (ARR).
Cohesity’s net expansion rate continues to exceed 130% as of 31 July 2021, a benchmark for leading subscription/SaaS companies. This means that ARR from Cohesity’s existing customers grew by more than 30% over the year.
The company has raised a total of $660 million in funding over 5 rounds. The latest funding was raised in April 2020 from a Series E round at a $2.5 billion valuation. Cohesity is funded by 25 investors, including Sequoia Capital, Baillie Gifford, SoftBank Vision Fund, Hewlett Packard Enterprise, Cisco, Accel, GV.
United Traders analysts are in continuous search for OTC offers studying financial reporting, companies’ businesses, their future plans, analyzing them as potential acquisition targets or estimating prospective multifold capitalization increase as well as considering risks that may hinder business growth. The best ideas are offered to our investors.
As part of our service for purchasing shares on the over-the-counter market (pre-IPO, OTC), for its traders and investors United Traders buys units in funds that own equity stakes in private companies. These funds make early-stage investments in private companies or acquire equity stakes from employees of such companies.
United Traders will have shares at its disposal after the IPO. The shares can be sold after the established 6-month Lock-up period. Alternatively, the shares can be hedged for the above period. Prior to the company going public United Traders look for exit options in the OTC market. If we find a great offer, we sell the shares.
After the Lock-up period is over, the investment in pre-IPO or OTC will be automatically closed, and generated profits are credited to your account less the applicable UT fees. We offer an opportunity for investors with over $100,000 invested in a specific idea to search for a counterpart in the OTC market individually and to take profits before the company goes public and thereby exiting the trade prior to the Lock-up period expiration.
Although it is prohibited to sell shares within the Lock-Up period, our traders find ways to take profits for our investors using various financial instruments: forwards, options, short selling trades, etc.
For an investor the above means that the pre-IPO or OTC investment may be exited after paying a part of its value, usually around 15% which is caused by highly-priced instruments used to close the position. To do so, you should press the respective button in your members area as soon as it becomes active.
The exiting process is similar to making a new investment. You submit a request, we execute it within 1 business day, and your investment is closed at the current exchange price.
3.5% of the share purchase amount. The fee is charged at confirmation of your investment bid.
0.5% of the share sell amount after the trade. The fee is charged at the investment exit.
20% of the profit gain. The fee is charged only if the trade is profitable at the time of exiting.
EARLY EXIT FEE
Usually a 15% fee is charged subject to the actual situation at the exchange. The fee is calculated individually for each investment.
WE ARE A RELIABLE PARTNER
Our risk managers will support you throughout the entire transaction life.
Venture investing is very risky as they involve new or growing companies, and multifold increase in capitalization is expected. We prioritize companies at the pre-IPO stage as they already demonstrate strong financial indicators and plan to go public soon. This approach allows limiting hyper-risks related to insolvency of new companies and substantially increasing profits as compared to investors who buy shares through a subscription just before the IPO.
LOW ENTRY THRESHOLD
To buy the OTC stocks, one would need millions of dollars. We gathered a pool of traders and investors allowing everyone interested to join similar transactions with as much as $10.
United Traders is experienced in minimizing risks but a future investor should be aware of all risk types:
- Illiquidity. There is a possibility that early exit from this investment will take more than 1 month.
- Asymmetric information. Management and current investors have access to more internal information about the company than other market participants.
- Time uncertainty. There is no information regarding next financing round or exit strategy timeframe (IPO or M&A).
- Share dilution. The issue of additional shares by a company may reduce the value of shares of existing investors.